ClinicalTrials.gov
public full text
Public Domain
ARIpiprazole in Anorexia NErvosa
Evidence is lacking on the effects of different psychotropic drugs in the treatment of anorexia nervosa (AR). However, HVA levels seem to be elevated in this disease, therefore suggesting a role for drugs with a partial agonist profile on dopaminergic receptors. This is a pilot study assessing the effects of aripiprazole in teenagers with AR, compared with a placebo.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Aripiprazole Effects on Alcohol Reactivity and Consumption#860897
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)#1152056
- Aripiprazole in Children and Adolescents With Bipolar I Disorder#1173066
- Aripiprazole for Bipolar Disorder and Alcohol Use Disorder#852876
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study#899066
Record · ID 969736
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive